Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Sep 28, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newly diagnosed pulmonary nodule with plan for surveillance
- • Active smoker
- • Receiving care at the Portland VA Health Care System, the Minneapolis VA Health Care System, or the Ralph H. Johnson Medical Center (Charleston, SC VA)
- Exclusion Criteria:
- • -No exclusion criteria
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Portland, Oregon, United States
Charleston, South Carolina, United States
Minneapolis, Minnesota, United States
Portland, Oregon, United States
Patients applied
Trial Officials
Christopher G. Slatore, MD MS
Principal Investigator
VA Portland Health Care System, Portland, OR
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials